Skip to main content

Ongoing FDAEvent 99219 (3 months ago)

Think Surgical TMINI Femur and Tibia Tracking Arrays

The TMINI Femur and Tibia Tracking Arrays may loosen at the knob, causing misalignment.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

Think Surgical, Inc., of Fremont, California, recalled the TMINI Femur Tracking Array REF 109003 and TMINI Tibia Tracking Array REF 109004 due to a manufacturing/design issue where the knob on the tracking array may loosen, causing potential misalignment of the array.

The TMINI Miniature Robotic System is indicated as a stereotaxic instrumentation system for total knee replacement (TKA) surgery, assisting the surgeon by providing software-defined spatial boundaries for orientation and reference information to identifiable anatomical structures for accurate placement of knee implant components.

The recall began May 8, 2026, and was added to the FDA's Enforcement Report on July 9, 2026.

The recall covers 360 devices distributed in the states of AZ, CA, DE, FL, IA, KS, LA, MI, MN, MO, MS, NC, NE, NJ, NV, NY, OH, OR, PA, TX, UT, VA, and WA.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Compare these product details with yours, then check the recall notice for any restrictions.

  1. TMINI Femur Tracking Array REF 109003 UDI-DI code: M9461090030 TMINI Tibia Tracking Array REF 109004 UDI-DI code: M9461090040 TMINI Miniature Robotic System

Details

Company began the recall
Event ID
99219
Recall No.
Z-2716-2026
Company
Think Surgical, Inc.Fremont, California
Quantity recalled
360 devices
Recall type
Voluntary: Firm initiated
Customers told by
Letter
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration